Skip to content

Study on the Regulatory Effects of Personalized Innovative Youtiao Intervention on Nutritional Health

Study on the Regulatory Effects of Personalized Innovative Youtiao Intervention on Nutritional Health

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06422429
Enrollment
150
Registered
2024-05-21
Start date
2025-03-01
Completion date
2025-12-01
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolism and Nutrition Disorder

Brief summary

The goal of this clinical trial is to investigate the effects of personalized innovative fritters on the nutritional health of overweight and obese individuals aged 40 to 70 years. The main questions it aims to answer are: * How does consuming personalized innovative fritters affect the nutritional health of overweight and obese individuals? * What is the mechanism underlying the impact of personalized innovative oil bars on nutritional health? Participants will be randomly assigned to one of two groups: a trial group consuming personalized innovative fritters and a control group consuming traditional fritters with equal energy content. Over the course of 6 months, participants will undergo two phases of intervention separated by a two-month washout period. During the intervention, participants will be assessed comprehensively for sensory ratings and nutritional health status through biological indicators, physical examinations, and other relevant measures. Researchers will compare the trial group to the control group to determine if personalized innovative fritters lead to improvements in nutritional health compared to traditional fritters.

Detailed description

Participants entered the trial with a 1-week equilibration period during which baked and fried foods were prohibited. The test group will consume personalised innovative Youtiao and the control group will uniformly consume traditional Youtiao of equal energy, 45 g 4 times per week for 8 weeks, during which time we will periodically measure biological indicators and collect biological samples to gain insight into the effects of the personalised innovative Youtiao on the participants. After completion of the 8-week intervention, a washout phase is entered. During this phase, participants will no longer ingest the Youtiao to see how they trend after stopping the intervention. Participants then enter the second phase of the trial, where the intervention process described above is continued with appropriate consumption adjustments based on the initial results of the first phase of the intervention.

Interventions

DRUGTraditional deep-fried Youtiao

45g 4 times a week for 4 months

DRUGPI Youtiao

45g 4 times a week for 4 months

Sponsors

Yu Zhang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age between 40-70 years old (women need to be menopausal); * BMI\>24 kg/m2; * Consumption of fritters more than once a week.

Exclusion criteria

* history of diabetes mellitus, cardiovascular disease, dyslipidaemia, renal disease, - * liver disease or cancer; * surgical treatment within 3 months; * allergy/intolerance to the study food or any of its ingredients; * breastfeeding or pregnancy; * \>10% weight loss in the past 6 months; * smoking or alcohol abuse; * participation in another clinical study within the past 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change in HbA1c6 monthsThe investigators will measure HbA1c in blood samples before and after treatment.
Change in blood glucose from baseline6 monthsThe investigators will measure fasting plasma glucose levels in blood samples before and after treatment.

Secondary

MeasureTime frameDescription
Change in blood lipids from baseline6 monthsThe investigators will measure Triglycerides (TG), total cholesterol (TC), LDL-C, and HDL-C levels in blood samples before and after treatment.

Contacts

Primary ContactYu Zhang, PHD
yzhang@zju.edu.cn86-0571-88982211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026